| ISIN | IE00BKWQ0H23 | 
|---|---|
| Valor Number | 24767202 | 
| Bloomberg Global ID | |
| Fund Name | SPDR MSCI Europe Health Care UCITS ETF EUR | 
| Fund Provider | State Street Investment Management
                                            
    
        Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) | 
| Fund Provider | State Street Investment Management | 
| Representative in Switzerland | State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 | 
| Distributor(s) | State Street Global Advisors | 
| Asset Class | Equities | 
| EFC Category | |
| Distribution Policy | Accumulation | 
| Home Country | Ireland | 
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund | 
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund | 
| Investment Strategy *** | The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. | 
| Peculiarities | 
| Current Price * | 211.86 EUR | 30.10.2025 | 
|---|---|---|
| Previous Price * | 212.12 EUR | 29.10.2025 | 
| 52 Week High * | 231.91 EUR | 03.03.2025 | 
| 52 Week Low * | 182.04 EUR | 09.04.2025 | 
| NAV * | 211.86 EUR | 30.10.2025 | 
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 643,536,063 | |
| Unit/Share Assets *** | 643,536,063 | |
| Trading Information SIX | ||
| YTD Performance | +1.03% | 31.12.2024 - 30.10.2025
        31.12.2024 30.10.2025 | 
|---|---|---|
| YTD Performance (in CHF) | -0.24% | 31.12.2024 - 30.10.2025
        31.12.2024 30.10.2025 | 
| 1 month | +4.84% | 30.09.2025 - 30.10.2025
        30.09.2025 30.10.2025 | 
| 3 months | +5.56% | 30.07.2025 - 30.10.2025
        30.07.2025 30.10.2025 | 
| 6 months | +3.30% | 30.04.2025 - 30.10.2025
        30.04.2025 30.10.2025 | 
| 1 year | -5.76% | 30.10.2024 - 30.10.2025
        30.10.2024 30.10.2025 | 
| 2 years | +11.01% | 30.10.2023 - 30.10.2025
        30.10.2023 30.10.2025 | 
| 3 years | +15.35% | 31.10.2022 - 30.10.2025
        31.10.2022 30.10.2025 | 
| 5 years | +44.56% | 30.10.2020 - 30.10.2025
        30.10.2020 30.10.2025 | 
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 14.08% | |
|---|---|---|
| AstraZeneca PLC | 13.74% | |
| Roche Holding AG | 13.51% | |
| Novo Nordisk AS Class B | 10.28% | |
| Sanofi SA | 6.01% | |
| Essilorluxottica | 5.75% | |
| GSK PLC | 5.10% | |
| Lonza Group Ltd | 2.74% | |
| argenx SE | 2.61% | |
| Haleon PLC | 2.37% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.18% | 
|---|---|
| TER date *** | 31.03.2025 | 
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.18% | 
| Ongoing Charges *** | 0.18% | 
| SRRI *** | |
| SRRI date *** | 30.09.2025 |